Global Biological Safety Testing Market Insights, Opportunity Analysis, Market Shares and Forecast, 2017 - 2023

  • ID: 4340226
  • Report
  • Region: Global
  • 190 pages
  • Occams Business Research and Consulting
1 of 4
The Global Biological Safety Testing Market is Expected to Have a CAGR of 13% During the 2016-2023.

FEATURED COMPANIES

  • Avance Biosciences (U.S.)
  • Merck Kgaa (Germany)
  • Nuaire (U.S.)
  • Sartorius Ag (Germany)
  • SGS Sa (Switzerland)
  • Source Bioscience (U.K.)
  • MORE
Biological safety testing is a method that involves testing the safety of all pharmaceuticals such as vaccines and medicinal drugs. The global biological safety testing market is expected to grow at the CAGR of 13% during the forecast period of 2016-2023. Drug launches in recent years mainly contributes to the growth of the global biological safety testing market during the forecast period. However, high healthcare and investment cost and lack of regulatory framework are the factors restraining the growth of the global biological safety testing market during the forecast period.

Geographically, North America accounted for the largest market share in terms of revenue for the biological safety testing market in 2016 followed by Europe. North America is expected to dominate the market during the forecast period. The growth in the region is witnessed owing to adoption of biotechnology in cancer research. Asia Pacific is expected to be the fastest growing region for biological safety testing market during the forecast period due to presence of emerging economies in the region such as China, India and South Korea.

The growth in global biological safety testing market is also influenced by the presence of major players such as Thermo Fisher Scientific Inc. (U.S.), SGS SA (Switzerland), Lonza Group Ltd. (Switzerland), Merck KGAA (Germany), Wuxi Apptec (China) etc. product launches, partnetships, mergers & acquisitions etc. are some of the crucial strategies which are adopted by the major players to gain competitive advantage.

Global biological safety testing market report covers segmentation analysis of product, test and applications. Report further covers segments of product which include instruments, kits and reagents and services. Kits and reagents are expected to dominate the segment during the forecast period. The dominance of the segment is attributed to its high popularity and launch of more efficient technologies during the forecast period. Moreover, the test types in biological safety testing are divided as adventitious agent detection test, bio burden test, cell line authentication and characterization test, endo toxin test, residual host contamination detection test, sterility test and other tests. The endo toxin tests and sterility tests segment is expected to dominate the market during the forecast period owing to increasing awareness and implication of stringent regulations.

Furthermore, the applications of biological safety testing include blood and blood related products testing, cellular and gene therapy, stem cell research, tissue and tissue related products testing and vaccine and therapeutic development. Vaccine and therapeutic development is expected to dominate the market during the forecast period owing to increasing investments in vaccine development.

Note:
Please allow up to 72 hours for delivery.
READ MORE
Note: Product cover images may vary from those shown
2 of 4

FEATURED COMPANIES

  • Avance Biosciences (U.S.)
  • Merck Kgaa (Germany)
  • Nuaire (U.S.)
  • Sartorius Ag (Germany)
  • SGS Sa (Switzerland)
  • Source Bioscience (U.K.)
  • MORE
1. Introduction
1.1. Executive Summary
1.2. Estimation Methodology

2. Market Overview
2.1. Biological Safety Testing Market: Evolution & Transition
2.2. Market Definition & Scope
2.3. Industry Structure
2.4. Regulatory Framework
2.5. Total Market Analysis
2.5.1. Top 5 Findings
2.5.2. Top 5 Opportunity Markets
2.5.3. Top 5 Companies
2.5.4. Top 3 Competitive Strategies
2.6. Estimation Analysis
2.7. Strategic Analysis
2.7.1. Investment Vs. Adoption Model
2.7.2. 360-Degree Industry Analysis
2.7.3. Porters 5 Force Model
2.7.4. See-Saw Analysis
2.7.5. Consumer Analysis And Key Buying Criteria
2.8. Competitive Analysis
2.8.1. Key Strategies & Analysis
2.8.2. Market Share Analysis And Top Company Analysis
2.9. Strategic Recommendations & Key Conclusions
2.9.1. Investment Opportunities By Regions
2.9.2. Opportunities in Emerging Applications
2.9.3. Investment Opportunity in Fastest Growing Segment

3. Market Determinants
3.1. Market Drivers
3.1.1. Increasing Prevalance of Chronic Deseases Globally
3.1.2. Increase in Number of Drug Launches
3.1.3. Growth of Biotechnology And Biopharmaceuticals Industries
3.1.4. R & D Investments in Life Science
3.1.5. Stringent Regulations Issued By Healthcare Organizations
3.2. Market Restraints
3.2.1. High Healthcare And Investment Costs
3.2.2. Lack of Regulatory Framework
3.3. Market Opportunities
3.3.1. Increasing Pharmaceutical Outsourcing
3.3.2. Increasing Applications in Therapeutics And Expansion In Asia Pacific
3.4. Market Challenges
3.4.1. Lack of Skilled Professionals

4. Market Segmentation
4.1.1. Biological Safety Testing Market By Product
4.1.2. Market Definition And Scope
4.1.3. Decision Support Database & Estimation Methodology
4.1.4. Comparative Analysis Across Market Segments
4.1.5. Opportunity Matrix
4.1.6. Market Segmentation
4.1.6.1. Global Instruments Market
4.1.6.1.1. Adoption Scenario & Market Determinants
4.1.6.1.2. Market Estimations And Forecasts 2014-2023 ($ Million)
4.1.6.1.3. Top Players & Key Products
4.1.6.1.4. Key Conclusions
4.1.6.2. Global Kits And Reagents Market
4.1.6.2.1. Adoption Scenario & Market Determinants
4.1.6.2.2. Market Estimations And Forecasts 2014-2023 ($ Million)
4.1.6.2.3. Top Players & Key Products
4.1.6.2.4. Key Conclusions
4.1.6.3. Global Services Market
4.1.6.3.1. Application
4.1.6.3.2. Adoption Scenario & Market Determinants
4.1.6.3.3. Market Estimations And Forecasts 2014-2023 ($ Million)
4.1.6.3.4. Top Players & Key Products
4.1.6.3.5. Key Conclusions
4.2. Biological Safety Testing Market By Test Type
4.2.1. Market Definition And Scope
4.2.2. Decision Support Database & Estimation Methodology
4.2.3. Comparative Analysis Across Market Segments
4.2.4. Opportunity Matrix
4.2.5. Market Segmentation
4.2.5.1. Global Adventitious Agent Detection Tests Market
4.2.5.1.1. Application
4.2.5.1.2. Adoption Scenario & Market Determinants
4.2.5.1.3. Market Estimations And Forecasts 2014-2023 ($ Million)
4.2.5.1.4. Top Players & Key Products
4.2.5.1.5. Key Conclusions
4.2.5.2. Global Bioburden Tests Market
4.2.5.2.1. Application
4.2.5.2.2. Adoption Scenario & Market Determinants
4.2.5.2.3. Market Estimations And Forecasts 2014-2023 ($ Million)
4.2.5.2.4. Top Players & Key Products
4.2.5.2.5. Key Conclusions
4.2.5.3. Global Cell Line Authentication And Characterization Tests Market
4.2.5.3.1. Application
4.2.5.3.2. Adoption Scenario & Market Determinants
4.2.5.3.3. Market Estimations And Forecasts 2014-2023 ($ Million)
4.2.5.3.4. Top Players & Key Products
4.2.5.3.5. Key Conclusions
4.2.5.4. Global Endotoxin Tests Market
4.2.5.4.1. Application
4.2.5.4.2. Adoption Scenario & Market Determinants
4.2.5.4.3. Market Estimations And Forecasts 2014-2023 ($ Million)
4.2.5.4.4. Top Players & Key Products
4.2.5.4.5. Key Conclusions
4.2.5.5. Global Residual Host Contamination Detection Tests Market
4.2.5.5.1. Application
4.2.5.5.2. Adoption Scenario & Market Determinants
4.2.5.5.3. Market Estimations And Forecasts 2014-2023 ($ Million)
4.2.5.5.4. Top Players & Key Products
4.2.5.5.5. Key Conclusions
4.2.5.6. Global Sterility Tests Market
4.2.5.6.1. Application
4.2.5.6.2. Adoption Scenario & Market Determinants
4.2.5.6.3. Market Estimations And Forecasts 2014-2023 ($ Million)
4.2.5.6.4. Top Players & Key Products
4.2.5.6.5. Key Conclusions
4.2.5.7. Global Others Market
4.2.5.7.1. Application
4.2.5.7.2. Adoption Scenario & Market Determinants
4.2.5.7.3. Market Estimations And Forecasts 2014-2023 ($ Million)
4.2.5.7.4. Top Players & Key Products
4.2.5.7.5. Key Conclusions
4.3. Biological Safety Testing Market By Application
4.3.1. Market Definition And Scope
4.3.2. Decision Support Database & Estimation Methodology
4.3.3. Comparative Analysis Across Market Segments
4.3.4. Opportunity Matrix
4.3.5. Market Segmentation
4.3.5.1. Global Blood And Blood Related Products Testing Market
4.3.5.1.1. Application
4.3.5.1.2. Adoption Scenario & Market Determinants
4.3.5.1.3. Market Estimations And Forecasts 2014-2023 ($ Million)
4.3.5.1.4. Top Players & Key Products
4.3.5.1.5. Key Conclusions
4.3.5.2. Global Cellular And Gene Therapy Market
4.3.5.2.1. Application
4.3.5.2.2. Adoption Scenario & Market Determinants
4.3.5.2.3. Market Estimations And Forecasts 2014-2023 ($ Million)
4.3.5.2.4. Top Players & Key Products
4.3.5.2.5. Key Conclusions
4.3.5.3. Global Stem Cell Research Market
4.3.5.3.1. Application
4.3.5.3.2. Adoption Scenario & Market Determinants
4.3.5.3.3. Market Estimations And Forecasts 2014-2023 ($ Million)
4.3.5.3.4. Top Players & Key Products
4.3.5.3.5. Key Conclusions
4.3.5.4. Global Tissue And Tissue Related Products Testing Market
4.3.5.4.1. Application
4.3.5.4.2. Adoption Scenario & Market Determinants
4.3.5.4.3. Market Estimations And Forecasts 2014-2023 ($ Million)
4.3.5.4.4. Top Players & Key Products
4.3.5.4.5. Key Conclusions
4.3.5.5. Global Vaccine And Therapeutics Development Market
4.3.5.5.1. Application
4.3.5.5.2. Adoption Scenario & Market Determinants
4.3.5.5.3. Market Estimations And Forecasts 2014-2023 ($ Million)
4.3.5.5.4. Top Players & Key Products
4.3.5.5.5. Key Conclusions

5. Competitive Landscape
5.1. Key Strategies
5.1.1. List of Mergers And Acquisition
5.1.2. List of Joint Ventures
5.1.3. List of Product Launches
5.1.4. List of Partnerships

6. Geographical Analysis
6.1. Decision Support Database & Estimation Methodology
6.2. Comparative Analysis Across Market Segments
6.3. Opportunity Matrix
6.4. Global Biological Safety Testing Market By Region 2014-2023 ($ Million)
6.4.1. North America
6.4.1.1. Industry Analysis 2014-2023 ($ Million)
6.4.1.2. Top Country Analysis
6.4.1.2.1. U.S.
6.4.1.2.1.1. Market Estimations And Forecasts 2014-2023 ($ Million)
6.4.1.2.1.2. Top Players & Key Products
6.4.1.2.1.3. Key Conclusions
6.4.1.2.2. Canada
6.4.1.2.2.1. Market Estimations And Forecasts 2014-2023 ($ Million)
6.4.1.2.2.2. Top Players & Key Products
6.4.1.2.2.3. Key Conclusions
6.4.2. Europe
6.4.2.1. Industry Analysis 2014-2023 ($ Million)
6.4.2.2. Top Country Analysis
6.4.2.2.1. Uk
6.4.2.2.1.1. Market Estimations And Forecasts 2014-2023 ($ Million)
6.4.2.2.1.2. Top Players & Key Products
6.4.2.2.1.3. Key Conclusions
6.4.2.2.2. France
6.4.2.2.2.1. Market Estimations And Forecasts 2014-2023 ($ Million)
6.4.2.2.2.2. Top Players & Key Products
6.4.2.2.2.3. Key Conclusions
6.4.2.2.3. Germany
6.4.2.2.3.1. Market Estimations And Forecasts 2014-2023 ($ Million)
6.4.2.2.3.2. Top Players & Key Products
6.4.2.2.3.3. Key Conclusions
6.4.2.2.4. Spain
6.4.2.2.4.1. Market Estimations And Forecasts 2014-2023 ($ Million)
6.4.2.2.4.2. Top Players & Key Products
6.4.2.2.4.3. Key Conclusions
6.4.2.2.5. Rest of Europe
6.4.2.2.5.1. Market Estimations And Forecasts 2014-2023 ($ Million)
6.4.2.2.5.2. Top Players & Key Products
6.4.2.2.5.3. Key Conclusions
6.4.3. Asia Pacific
6.4.3.1. Industry Analysis 2014-2023 ($ Million)
6.4.3.2. Top Country Analysis
6.4.3.2.1. China
6.4.3.2.1.1. Market Estimations And Forecasts 2014-2023 ($ Million)
6.4.3.2.1.2. Top Players & Key Products
6.4.3.2.1.3. Key Conclusions
6.4.3.2.2. India
6.4.3.2.2.1. Market Estimations And Forecasts 2014-2023 ($ Million)
6.4.3.2.2.2. Top Players & Key Products
6.4.3.2.2.3. Key Conclusions
6.4.3.2.3. Japan
6.4.3.2.3.1. Market Estimations And Forecasts 2014-2023 ($ Million)
6.4.3.2.3.2. Top Players & Key Products
6.4.3.2.3.3. Key Conclusions
6.4.3.2.4. Australia
6.4.3.2.4.1. Market Estimations And Forecasts 2014-2023 ($ Million)
6.4.3.2.4.2. Top Players & Key Products
6.4.3.2.4.3. Key Conclusions
6.4.3.2.5. Rest of Asia Pacific
6.4.3.2.5.1. Market Estimations And Forecasts 2014-2023 ($ Million)
6.4.3.2.5.2. Top Players & Key Products
6.4.3.2.5.3. Key Conclusions
6.4.4. Row
6.4.4.1. Industry Analysis 2014-2023 ($ Million)
6.4.4.2. Top Country Analysis
6.4.4.2.1. Latin America
6.4.4.2.1.1. Market Estimations And Forecasts 2014-2023 ($ Million)
6.4.4.2.1.2. Top Players & Key Products
6.4.4.2.1.3. Key Conclusions
6.4.4.2.2. Middle East & Africa
6.4.4.2.2.1. Market Estimations And Forecasts 2014-2023 ($ Million)
6.4.4.2.2.2. Top Players & Key Products
6.4.4.2.2.3. Key Conclusions

7. Company Profiles
7.1. Lonza Group Ltd. (Switzerland)
7.1.1. Overview
7.1.2. Product Portfolio
7.1.3. Key Innovation Sector
7.1.4. Strategic Initiatives
7.1.5. Scot Analysis
7.1.6. Strategic Analysis
7.2. Charles River Laboratories (U.S.)
7.2.1. Overview
7.2.2. Product Portfolio
7.2.3. Key Innovation Sector
7.2.4. Strategic Initiatives
7.2.5. Scot Analysis
7.2.6. Strategic Analysis
7.3. Merck Kgaa (Germany)
7.3.1. Overview
7.3.2. Product Portfolio
7.3.3. Key Innovation Sector
7.3.4. Strategic Initiatives
7.3.5. Scot Analysis
7.3.6. Strategic Analysis
7.4. Sgs Sa (Switzerland)
7.4.1. Overview
7.4.2. Product Portfolio
7.4.3. Key Innovation Sector
7.4.4. Strategic Initiatives
7.4.5. Scot Analysis
7.4.6. Strategic Analysis
7.5. Wuxi Apptec (China)
7.5.1. Overview
7.5.2. Product Portfolio
7.5.3. Key Innovation Sector
7.5.4. Strategic Initiatives
7.5.5. Scot Analysis
7.5.6. Strategic Analysis
7.6. Thermo Fisher Scientific Inc. (U.S.)
7.6.1. Overview
7.6.2. Product Portfolio
7.6.3. Key Innovation Sector
7.6.4. Strategic Initiatives
7.6.5. Scot Analysis
7.6.6. Strategic Analysis
7.7. Sartorius Ag (Germany)
7.7.1. Overview
7.7.2. Product Portfolio
7.7.3. Key Innovation Sector
7.7.4. Strategic Initiatives
7.7.5. Scot Analysis
7.7.6. Strategic Analysis
7.8. Cytovance Biologics Inc. (U.S.)
7.8.1. Overview
7.8.2. Product Portfolio
7.8.3. Key Innovation Sector
7.8.4. Strategic Initiatives
7.8.5. Scot Analysis
7.8.6. Strategic Analysis
7.9. Pace Analytical Services Inc. (U.S.)
7.9.1. Overview
7.9.2. Product Portfolio
7.9.3. Key Innovation Sector
7.9.4. Strategic Initiatives
7.9.5. Scot Analysis
7.9.6. Strategic Analysis
7.10. Toxikon Corporation (U.S.)
7.10.1. Overview
7.10.2. Product Portfolio
7.10.3. Key Innovation Sector
7.10.4. Strategic Initiatives
7.10.5. Scot Analysis
7.10.6. Strategic Analysis
7.11. Avance Biosciences (U.S.)
7.11.1. Overview
7.11.2. Product Portfolio
7.11.3. Key Innovation Sector
7.11.4. Strategic Initiatives
7.11.5. Scot Analysis
7.11.6. Strategic Analysis
7.12. Nuaire (U.S.)
7.12.1. Overview
7.12.2. Product Portfolio
7.12.3. Key Innovation Sector
7.12.4. Strategic Initiatives
7.12.5. Scot Analysis
7.12.6. Strategic Analysis
7.13. Paragon Bioservices Inc. (U.S.)
7.13.1. Overview
7.13.2. Product Portfolio
7.13.3. Key Innovation Sector
7.13.4. Strategic Initiatives
7.13.5. Scot Analysis
7.13.6. Strategic Analysis
7.14. Nordic Scientific And Natural Solutions Ab (Sweden)
7.14.1. Overview
7.14.2. Product Portfolio
7.14.3. Key Innovation Sector
7.14.4. Strategic Initiatives
7.14.5. Scot Analysis
7.14.6. Strategic Analysis
7.15. Source Bioscience (U.K.)
7.15.1. Overview
7.15.2. Product Portfolio
7.15.3. Key Innovation Sector
7.15.4. Strategic Initiatives
7.15.5. Scot Analysis
7.15.6. Strategic Analysis

List of Tables
1. Global Biological Safety Testing Market By Product 2014-2023 ($ Million)
2. Global Instruments Market By Geography 2014-2023 ($ Million)
3. Global Kits And Reagents Market By Geography 2014-2023 ($ Million)
4. Global Services Market By Geography 2014-2023 ($ Million)
5. Global Biological Safety Testing Market By Test Type 2014-2023 ($ Million)
6. Global Adventitious Agent Detection Tests Market By Geography 2014-2023 ($ Million)
7. Global Bioburden Tests Forensics Market By Geography 2014-2023 ($ Million)
8. Global Cell Line Authentication And Characterization Tests Market By Geography 2014-2023 ($ Million)
9. Global Endotoxin Tests Market By Geography 2014-2023 ($ Million)
10. Global Residual Host Contamination Detection Tests Market By Geography 2014-2023 ($ Million)
11. Global Sterlity Tests Market By Geography 2014-2023 ($ Million)
12. Global Others Market By Geography 2014-2023 ($ Million)
13. Global Biological Safety Testing Market By Application 2014-2023 ($ Million)
14. Global Blood And Blood Related Products Testing Market By Geography 2014-2023 ($ Million)
15. Global Cellular And Gene Therapy Market By Geography 2014-2023 ($ Million)
16. Global Stem Cell Research Market By Geography 2014-2023 ($ Million)
17. Global Tissue And Tissue Related Products Testing Market By Geography 2014-2023 ($ Million)
18. Global Vaccine And Therapeutics Development Market By Geography 2014-2023 ($ Million)
19. North America Biological Safety Testing Market 2014-2023 ($ Million)
20. Europe Biological Safety Testing Market 2014-2023 ($ Million)
21. Asia Pacific Biological Safety Testing Market 2014-2023 ($ Million)
22. Rest of the World Biological Safety Testing Market 2014-2023 ($ Million)

List of Figures
1. Global Biological Safety Testing Market 2014-2023 ($ Million)
2. Global Instruments Market 2014-2023 ($ Million)
3. Global Kits And Reagents Market 2014-2023 ($ Million)
4. Global Services Market 2014-2023 ($ Million)
5. Global Adventitious Agent Detection Tests Market 2014-2023 ($ Million)
6. Global Bioburden Tests Forensics Market 2014-2023 ($ Million)
7. Global Cell Line Authentication And Characterization Tests Market 2014-2023 ($ Million)
8. Global Endotoxin Tests Market 2014-2023 ($ Million)
9. Global Residual Host Contamination Detection Tests Market 2014-2023 ($ Million)
10. Global Sterlity Tests Market 2014-2023 ($ Million)
11. Global Others Market 2014-2023 ($ Million)
12. Global Blood And Blood Related Products Testing Market 2014-2023 ($ Million)
13. Global Cellular And Gene Therapy Market 2014-2023 ($ Million)
14. Global Stem Cell Research Market 2014-2023 ($ Million)
15. Global Tissue And Tissue Related Products Testing Market 2014-2023 ($ Million)
16. Global Vaccine And Therapeutics Development Market 2014-2023 ($ Million)
17. United States (U.S.) Biological Safety Testing Market 2014-2023 ($ Million)
18. Canada Biological Safety Testing Market 2014-2023 ($ Million)
19. United Kingdom (Uk) Biological Safety Testing Market 2014-2023 ($ Million)
20. France Biological Safety Testing Market 2014-2023 ($ Million)
21. Germany Biological Safety Testing Market 2014-2023 ($ Million)
22. Spain Biological Safety Testing Market 2014-2023 ($ Million)
23. Roe Biological Safety Testing Market 2014-2023 ($ Million)
24. India Biological Safety Testing Market 2014-2023 ($ Million)
25. China Biological Safety Testing Market 2014-2023 ($ Million)
26. Japan Biological Safety Testing Market 2014-2023 ($ Million)
27. Australia Biological Safety Testing Market 2014-2023 ($ Million)
28. Roapac Biological Safety Testing Market 2014-2023 ($ Million)
29. Latin America Biological Safety Testing Market 2014-2023 ($ Million)
30. Mena Biological Safety Testing Market 2014-2023 ($ Million)
Note: Product cover images may vary from those shown
3 of 4

Loading
LOADING...

4 of 4
  • Avance Biosciences (U.S.)
  • Charles River Laboratories (U.S.)
  • Cytovance Biologics Inc. (U.S.)
  • Lonza Group Ltd. (Switzerland)
  • Merck Kgaa (Germany)
  • Nordic Scientific And Natural Solutions Ab (Sweden)
  • Nuaire (U.S.)
  • Pace Analytical Services Inc. (U.S.)
  • Paragon Bioservices Inc. (U.S.)
  • Sartorius Ag (Germany)
  • SGS Sa (Switzerland)
  • Source Bioscience (U.K.)
  • Thermo Fisher Scientific Inc. (U.S.)
  • Toxikon Corporation (U.S.)
  • Wuxi Apptec (China)
Note: Product cover images may vary from those shown
5 of 4
Note: Product cover images may vary from those shown
Adroll
adroll